Study on the AGEs-reducing effects induced by test food intakes - Study on the AGEs-reducing effects induced by test food intakes

CPCC Company Limited0 sites21 target enrollmentJanuary 7, 2022

ConditionsHealthy male/female adults

Overview

Phase: 未知
Intervention: Not specified
Conditions: Healthy male/female adults
Sponsor: CPCC Company Limited
Enrollment: 21
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

January 7, 2022

End Date

April 25, 2021

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

CPCC Company Limited

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•(1\) Subjects with some kind of continuous medical treatment. (2\) Subjects who are now under the restriction of carbohydrate with dieting (losing some weight by exercises and meal\-controlling), and/or are planning to go on a diet, during this trial. (3\) All through this trial, subjects who have any difficulty in refraining from taking steadily (not less than three times a week) in the health\-specific/functional/supplementary/health foods, which might affect the test results. (4\) Subjects who are planning to change their lifestyle. (5\) Subjects with extremely irregular eating habits. (6\) Subjects having not less than once a week , restricting their mealtimes to no more than once a day, within the last three months. (7\) Subjects who extremely take alcohol. (8\) Pregnant, possibly pregnant, or lactating women. (9\) Subjects having present/previous medical history of serious diseases in heart, liver, kidney, and/or digestive organs. (10\) Subjects with drug and/or food allergies, especially in wheat, eggs and milk. (11\) Subjects who are now under the other clinical tests with some kind of medicine/food, or took part in those within four weeks before this trial, or are planning to participate in those after giving informed consent to take part in this trial. (12\) Subjects who donated over 200 mL of their whole blood and/or blood components within a month before this trial. (13\) Males who donated over 400 mL of their whole blood within the last three months before this trial. (14\) Females who donated over 400 mL of their whole blood within the last four months before this trial. (15\) Males who will be collected over 1200 mL of their blood within the last twelve months before this trial. (16\) Females who will be collected over 800 mL of their blood within the last twelve months before this trial. (17\) Others who have been determined as ineligible for participation, according to the principal/sub investigator's opinions.